2023
DOI: 10.3390/bios13121014
|View full text |Cite
|
Sign up to set email alerts
|

The Label-Free Detection and Identification of SARS-CoV-2 Using Surface-Enhanced Raman Spectroscopy and Principal Component Analysis

Lu Zhou,
Ambra Vestri,
Valentina Marchesano
et al.

Abstract: The World Health Organization (WHO) declared in a May 2023 announcement that the COVID-19 illness is no longer categorized as a Public Health Emergency of International Concern (PHEIC); nevertheless, it is still considered an actual threat to world health, social welfare and economic stability. Consequently, the development of a convenient, reliable and affordable approach for detecting and identifying SARS-CoV-2 and its emerging new variants is crucial. The fingerprint and signal amplification characteristics… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 62 publications
1
6
0
Order By: Relevance
“…84 Our system shows an LoD in some cases similar or even competitive with those reported. 84 Our aim with this test was to demonstrate the potential in terms of sensing of the proposed FPM and its performance that can be further improved, for example, by testing different functionalization processes. However, the value for the LoD estimated for our system of 88 PFU/mL is about 4−5 times lower than that of a commercial lateral flow assay (LFA) strip test for SARS-CoV-2 (300−500 PFU/ mL).…”
Section: Sers Sensing Of the Sars-cov-2supporting
confidence: 85%
See 4 more Smart Citations
“…84 Our system shows an LoD in some cases similar or even competitive with those reported. 84 Our aim with this test was to demonstrate the potential in terms of sensing of the proposed FPM and its performance that can be further improved, for example, by testing different functionalization processes. However, the value for the LoD estimated for our system of 88 PFU/mL is about 4−5 times lower than that of a commercial lateral flow assay (LFA) strip test for SARS-CoV-2 (300−500 PFU/ mL).…”
Section: Sers Sensing Of the Sars-cov-2supporting
confidence: 85%
“…We point out here that it is not a purpose of this work to realize the most sensitive assay for SARS-CoV-2 with best-performing of the LoD as those reported in literature even realized with different technologies . Our system shows an LoD in some cases similar or even competitive with those reported .…”
Section: Resultsmentioning
confidence: 71%
See 3 more Smart Citations